Mehdi Layeghifard

7PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 10, 2026
Extensive and differential platinum chemotherapy mutagenesis in livers of children.

|Jul 22, 2026
Prior therapy defines mutation profiles in childhood cancer at relapse.

|Nov 30, 2023
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma.

Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher

|Jan 05, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis.

Nicholas Light, Mehdi Layeghifard, Ayush Attery

|Dec 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.

Anita Villani, Scott Davidson, Nisha Kanwar

|Jul 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival.

Nathaniel D Anderson, Yael Babichev, Fabio Fuligni

Pageof 2

Frequent Collaborators

7 joint publications

Adam Shlien

5 joint publications

Nathaniel D Anderson

4 joint publications

David Malkin

3 joint publications

Sasha Blay